Literature DB >> 9988049

Effect of tylosin used as a growth promoter on the occurrence of macrolide-resistant enterococci and staphylococci in pigs.

F M Aarestrup1, B Carstensen.   

Abstract

This study was conducted to investigate the effect of tylosin used as a growth promoter on the occurrence of macrolide-resistant enterococci and staphylococci in pigs. Two identical feeding experiments with 10 pigs each were conducted to evaluate the effect of tylosin on the occurrence of erythromycin resistance among enterococci sampled from feces and Staphylococcus hyicus sampled by skin swabs. Half of the pigs were fed antibiotic-free feed and the other half feed with tylosin (30 microg/g) added. For each pig, weekly fecal samples and skin swabs were collected and examined for erythromycin-susceptible and erythromycin-resistant enterococci and S. hyicus, respectively. There was an immediate effect of tylosin on the fraction of resistant enterococci recovered, increasing by a factor 2.4; the effect on S. hyicus was more gradual, increasing at a rate of about 8% per day and totaling a five-fold increase over 20 days. Thus, a clear effect on resistance occurrence was demonstrated, not only in intestinal bacteria, but also on bacteria sampled from the skin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9988049     DOI: 10.1089/mdr.1998.4.307

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  14 in total

1.  Effects of tylosin use on erythromycin resistance in enterococci isolated from swine.

Authors:  Charlene R Jackson; Paula J Fedorka-Cray; John B Barrett; Scott R Ladely
Journal:  Appl Environ Microbiol       Date:  2004-07       Impact factor: 4.792

2.  In vitro model of colonization resistance by the enteric microbiota: effects of antimicrobial agents used in food-producing animals.

Authors:  R Doug Wagner; Shemedia J Johnson; Carl E Cerniglia
Journal:  Antimicrob Agents Chemother       Date:  2008-01-28       Impact factor: 5.191

3.  Effects of flavophospholipol on resistance in fecal Escherichia coli and enterococci of fattening pigs.

Authors:  A E van den Bogaard; M Hazen; M Hoyer; P Oostenbach; E E Stobberingh
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

4.  Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark.

Authors:  F M Aarestrup; A M Seyfarth; H D Emborg; K Pedersen; R S Hendriksen; F Bager
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

5.  Antimicrobial growth promoter ban and resistance to macrolides and vancomycin in enterococci from pigs.

Authors:  P Boerlin; A Wissing; F M Aarestrup; J Frey; J Nicolet
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

Review 6.  Food animals and antimicrobials: impacts on human health.

Authors:  Bonnie M Marshall; Stuart B Levy
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

7.  Effect of macrolide usage on emergence of erythromycin-resistant Campylobacter isolates in chickens.

Authors:  Jun Lin; Meiguan Yan; Orhan Sahin; Sonia Pereira; Yun-Juan Chang; Qijing Zhang
Journal:  Antimicrob Agents Chemother       Date:  2007-03-12       Impact factor: 5.191

8.  Predominance of vanA genotype among vancomycin-resistant Enterococcus isolates from poultry and swine in Costa Rica.

Authors:  Warner Bustamante; Angélica Alpízar; Silvia Hernández; Alexandra Pacheco; Natalia Vargas; Marco Luis Herrera; Alvaro Vargas; Magaly Caballero; Fernando García
Journal:  Appl Environ Microbiol       Date:  2003-12       Impact factor: 4.792

9.  Assessment of bacterial antibiotic resistance transfer in the gut.

Authors:  Susanne Schjørring; Karen A Krogfelt
Journal:  Int J Microbiol       Date:  2011-01-24

Review 10.  Antimicrobial drug use in food-producing animals and associated human health risks: what, and how strong, is the evidence?

Authors:  Karin Hoelzer; Nora Wong; Joe Thomas; Kathy Talkington; Elizabeth Jungman; Allan Coukell
Journal:  BMC Vet Res       Date:  2017-07-04       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.